Immediate Impact
1 by Nobel laureates 5 from Science/Nature 58 standout
Citing Papers
Epigenetic drugs in cancer therapy
2025 Standout
Natural killer cell therapies
2024 StandoutNature
Works of Jennifer E. Amengual being referenced
Dual Targeting of EZH2 and HDAC with Tazemetostat and Belinostat Promotes Immunogenicity in GC-DLBCL
2021
A phase 1/2 trial of ublituximab, a novel anti‐ CD 20 monoclonal antibody, in patients with B‐cell non‐Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jennifer E. Amengual | 559 | 433 | 393 | 83 | 1.0k | |
| Lei Zhang | 294 | 506 | 474 | 57 | 975 | |
| Mark Bishton | 682 | 467 | 495 | 69 | 1.3k | |
| Daniela Buglio | 730 | 440 | 444 | 36 | 1.2k | |
| Ellen Leich | 595 | 533 | 548 | 50 | 1.4k | |
| Nagesh Kalakonda | 724 | 408 | 521 | 50 | 1.4k | |
| Georgios Z. Rassidakis | 480 | 364 | 405 | 34 | 1.0k | |
| D Germain | 399 | 301 | 191 | 44 | 866 | |
| Xiaorui Fu | 355 | 626 | 592 | 89 | 1.2k | |
| Gunhild Trøen | 423 | 316 | 264 | 46 | 1.0k | |
| Hyeon Seok Eom | 384 | 650 | 578 | 57 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...